Protective effect of steroidal saponins from rhizome of Anemarrhena asphodeloides on ovariectomy-induced bone loss in rats

Acta Pharmacologica Sinica

Volumn 27, Issue 6, 2006, Pages 728-734

  Nian, Hua ^a   Qin, Lu Ping ^a   Chen, Wan Sheng ^b   Zhang, Qiao Yan ^a   Zheng, Han Chen ^a   Wang, Yin ^c  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

^c No 455 Hospital of PLA   (China)

Author keywords

Anemarrhena asphodeloides; Bone mineral density; Histochemistry; Osteoporosis; Ovariectomy; Serum

Indexed keywords

ALKALINE PHOSPHATASE; ANEMARRHENA ASPHODELOIDES EXTRACT; CALCIUM; ESTRADIOL; NYLESTRIOL; OSTEOCALCIN; PHOSPHORUS; PLANT EXTRACT; SAPONIN DERIVATIVE; STEROID; UNCLASSIFIED DRUG;

ALKALINE PHOSPHATASE BLOOD LEVEL; ANEMARRHENA; ANEMARRHENA ASPHODELOIDES; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE ATROPHY; BONE DENSITY; CALCIUM BLOOD LEVEL; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME ACTIVITY; ESTRADIOL BLOOD LEVEL; FEMALE; HISTOLOGY; METAPHYSIS; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOLYSIS; OVARIECTOMY; PHOSPHATE BLOOD LEVEL; RHIZOME; STAINING; THICKNESS; TIBIA; TRABECULAR BONE;

ALKALINE PHOSPHATASE; ANEMARRHENA; ANIMALS; BONE DENSITY; BONE RESORPTION; CALCIUM; DRUGS, CHINESE HERBAL; ESTRADIOL; FEMALE; OSTEOCALCIN; OSTEOCLASTS; OSTEOGENESIS; OSTEOPOROSIS; OVARIECTOMY; PLANTS, MEDICINAL; RATS; RATS, SPRAGUE-DAWLEY; RHIZOME; SAPONINS;

EID: 33745353094     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2006.00328.x     Document Type: Article

References (25)

1. Kelly PJ. Is osteoporosis a genetically determined disease Br J Obstet Gynaecol 1996 103 : 20 7.
2. Albright F Smith PH Richardson D. Postmenopausal osteoporosis: its clinical features. JAMA 1941 116 : 2465 74.
3. Cummings SR Rubin SM Black D. The future of hip fractures in the United States: number, costs and potential effects of postmenopausal estrogen. Clin Orthop 1990 252 : 163 6.
4. Harada SI Rodan GA. Control of osteoblast function and regulation of bone mass. Nature 2003 423 : 349 55.
5. Davison S Davis SR. Hormone replacement therapy: current controversies. Clin Endocrinol 2003 58 : 249 61.
6. Nelson HD Humphrey LL Nygren P Teutsch SM Allan JD. Postmenopausal hormone replacement therapy: scientific review. JAMA 2002 288 : 872 81.
7. Tsukamoto S Wakana T Koimaru K Yoshida T Sato M Ohta T. 7-hydroxy-3-(4-hydroxybenzyl)chroman and broussonin b: neurotrophic compounds, isolated from Anemarrhena asphodeloides bunge, function as proteasome inhibitors. Biol Pharm Bull 2005 28 : 1798 800.
8. Hoa NK Phan DV Thuan ND Ostenson CG. Insulin secretion is stimulated by ethanol extract of Anemarrhena asphodeloides in isolated islet of healthy Wistar and diabetic Goto-Kakizaki Rats. Exp Clin Endocrinol Diabetes 2004 112 : 520 5.
9. Miura T Ichiki H Iwamoto N Kato M Kubo M Sasaki H, et al. Antidiabetic activity of the rhizoma of Anemarrhena aspho-deloides and active components, mangiferin and its glucoside. Biol Pharm Bull 2001 24 : 1009 11.
10. Iida Y Oh KB Saito M Matsuoka H Kurata H Natsume M, et al. Detection of antifungal activity in Anemarrhena asphodeloides by sensitive BCT method and isolation of its active compound. J Agric Food Chem 1999 47 : 584 7.
11. Zhang J Meng Z Zhang M Ma D Xu S Kodama H. Effect of six steroidal saponins isolated from Anemarrhenae rhizoma on platelet aggregation and hemolysis in human blood. Clin Chim Acta 1999 289 : 79 88. Chinese.
12. Pharmacopoeia Commission of People's Republic of China. Pharmacopoeia of the People's Republic of China. Beijing : Chemical Industry Press 2000. Part I, p 267 8.
13. Jeong SJ Higuchi R Ono M Kuwano M Kim YC Miyamoto T. cis-hinokiresinol, a norlignan from Anemarrhena asphodeloides, inhibits angiogenic response in vitro and in vivo. Biol Pharm Bull 2003 26 : 1721 4.
14. Meng ZY Zhang JY Xu SX Sugahara K. Steroidal saponins from Anemarrhena asphodeloides and their effects on superox-ide generation. Planta Med 1999 65 : 661 3.
15. Ichiki H Miura T Kubo M Ishihara E Komatsu Y Tanigawa K, et al. New antidiabetic compounds, mangiferin and its glucoside. Biol Pharm Bull 1998 21 : 1389 90.
16. Aritomi M Kawasaki T. A new xanthone C-glucoside, position isomer of mangiferin, from Anemarrhena asphodeloides Bunge. Tetrahedron Lett 1969 12 : 941 4.
17. Kalu DN. The ovariectomized rat model of postmenopausal bone loss. Bone Miner 1991 15 : 175 92.
18. Kalu DN Liu CC Salerno E. Skeletal response of ovariectomized rats to low and high doses of 17|3-estradiol. Bone Miner 1991 14 : 175 87.
19. Delmas PD. Osteoporosis: Etiology, diagnosis and management. In : Riggs BL Melton J eidtiors. New York : Raven Press 1988. p 297 316.
20. Li X Takahashi M Kushida K Inoue T. The preventive and interventional effects of raloxifene analog (LY117018HCL) on osteopenia in ovariectomized rats. J Bone Miner Res 1998 13 : 1005 10.
21. Burkman RT Collins JA Greene RA. Current perspectives on benefits and risks of hormone replacement therapy. Am J Obstet Gynecol 2001 185 : S13 S23.
22. Rodriguez C Patel AV Calle EE Jacob EJ Thun MJ. Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women. JAMA 2001 285 : 1460 5.
23. Messina M Messina V. Soyfoods, soybean isoflavones, and bone health: a brief overview. J Ren Nutr 2000 10 : 63 8.
24. Hofbauer LC Kuhne CA Viereck V. The OPG/RANKL/RANK system in metabolic bone diseases. J Musculoskel Neuron Interact 2004 4 : 268 75.
25. Yin J Tezuka Y Kouda K Tran QL Miyahara T Chen Y, et al. Antiosteoporotic activity of the water extract of dioscorea spongiosa. Biol Pharm Bull 2004 27 : 583 6.